Table 3.

Incidence of DSA among various disease cohorts of LTx recipients with pre-Tx Abs to lung restricted SAgs.

			DSA	Odds ratio	CI	p-value*
COPD	Pre-Tx Abs(+)	29	18 (62.07%)	2.2	1.0 – 5.1	0.055 (n/s)
	Pre-Tx Abs(−)	132	56 (42.42%)
	total	161	74 (45.96%)
IPF	Pre-Tx Abs(+)	17	12 (70.59%)	2.7	0.8 – 9.3	0.112 (n/s)
	Pre-Tx Abs(−)	33	17 (48.48%)
	total	50	28 (56%)
CF	Pre-Tx Abs(+)	16	10 (62.5%)	3.3	1.0 – 11.2	0.046
	Pre-Tx Abs(−)	39	13 (33.33%)
	total	55	23 (41.82%)
Others	Pre-Tx Abs(+)	10	5 (50%)	1.9	0.5 – 7.8	>0.8n/s
	Pre-Tx Abs(−)	41	14 (34.15%)
	total	51	19 (37.25%)

^*= Compared between pre-Tx Abs(+) and pre-Tx Abs(−) cohorts.